© 2023 MJH Life Sciences and Nutritional Outlook. All rights reserved.
© 2023 MJH Life Sciences™ and Nutritional Outlook. All rights reserved.
January 27, 2023
CBD is an established product that is paving the way for other hemp-derived cannabinoids. However, regulation remains a big if for the category.
January 19, 2023
A recent animal study conducted by the University of Alberta in Edmonton Canada compared the use of Ahiflower oil with soybean oil and fish oil during administration of total parenteral nutrition.
January 18, 2023
David Murray, the director of the Office of Disease Prevention at the National Institutes of Health, is currently serving as the acting director of the Office of Dietary Supplements (ODS) until a new, permanent ODS director is selected.
January 17, 2023
Results showed that, compared to placebo, subjects taking the black seed and astaxanthin blend reported significantly fewer upper-respiratory tract complaints and better overall well-being, as well as lower cortisol and superior microbiome indices.
January 16, 2023
Nutritional Growth Solutions has announced a new clinical study evaluating the effects of its sports nutrition supplement on the physical activity performance of young soccer players between the ages of 8 and 15 years
January 13, 2023
In cell cultures, the pomegranate extract was shown to modulate collagen and hyaluronic acid metabolism.
January 12, 2023
BGG’s work is included in USP’s “European Elder Berry Dry Extract” monograph.
January 06, 2023
Central to the discussion was a new study that is investigating the effects of 1 mg of MenaQ7 Vitamin K2 as MK-7 from Gnosis by Lesaffre versus placebo on arterial stiffness and the occurrence of cardiovascular events in end-stage renal disease patients undergoing peritoneal dialysis over the course of 1.5 years.
January 05, 2023
Vedic Lifesciences has completed recruitment of a pilot study to investigate the ability of a symbiotic to reduce recurrent bacterial vaginosis (BV) by restoring the natural microflora.
January 04, 2023
Under the guidance of Cheruba Prabakar, MD, a board certified OBGYN based in Lafayette, CA, the companies will study the effects of CBDV and CBC on menstrual pain and premenstrual pain symptoms over the course of two full menstrual cycles.